Skip to main content

Advertisement

SpringerLink
Log in

Once-daily versus thrice-daily administration of netilmicin in combination therapy ofPseudomonas aeruginosa infection in a man-adapted neutropenic animal model

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

A granulocytopenic mouse model was used to elucidate the impact of dose spacing on the activity of netilmicin againstPseudomonas aeruginosa. A thigh infection was produced and then treated with netilmicin combined with azlocillin. Netilmicin was injected subcutaneously at decreasing doses every 20 min to result in plasma-concentration-time curves similar to those observed in patients on intravenous netilmicin treatment. A once-daily regimen was simulated and compared to a simulated conventional schedule of every 8 h. Identical total amounts of drug were used in both groups of comparatively treated mice. Therapeutic efficacy was quantitated by repeated determinations of surviving organisms in thigh homogenates. Combination therapy was significantly more effective than azlocillin treatment alone. In combination regimens the simulated once-daily netilmicin schedule killed the target organisms faster than the simulated thrice-daily regimen and was significantly more efficacious by 24 and 32 h in two out of three strains ofPseudomonas aeruginosa tested. It is concluded that the results of combination therapy of severePseudomonas aeruginosa infections in the immunocompromised host might be improved by choosing an aminoglycoside dosage interval of 24 h instead of the conventional 8 h.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Drusano, G. L. Role of pharmacokinetics in the outcome of infections. Antimicrobial Agents and Chemotherapy 1988, 32: 289–297.

    PubMed  Google Scholar 

  2. Rolinson, G. N. Basis and results of therapy with beta-lactam antibiotics in experimental infections. Infection 1980, 8: 30–34.

    Article  Google Scholar 

  3. Gerber, A. U., Craig, W. A., Brugger, H. P., Feller, C., Vastola, A. P., Brandel, J. Impact of dosing intervals on activity of gentamicin and ticarcillin againstPseudomonas aeruginosa in granulocytopenic mice. Journal of Infectious Diseases 1983, 147: 910–917.

    PubMed  Google Scholar 

  4. Gerber, A. U., Feller, C., Brugger, H. P. Time course of the pharmacological response of beta-lactam antibiotics in vitro and in vivo: a rationale for dosage regimens. European Journal of Clinical Microbiology 1984, 3: 592–597.

    PubMed  Google Scholar 

  5. Roosendaal, R., Bakker-Woudenberg, I. A. J. M., van den Berghe-van Raffe, M., Michel, M. F. Continuous versus intermittent administration of ceftazidime in experimentalKlebsiella pneumoniae pneumonia in normal and leukopenic rats. Antimicrobial Agents and Chemotherapy 1986, 30: 403–408.

    PubMed  Google Scholar 

  6. Roosendaal, R., Bakker-Woudenberg, I. A. J. M., van den Berg, J. C., Michel, M. F. Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimentalKlebsiella pneumoniae pneumonia in rats. Journal of Infectious Diseases 1985, 152: 373–378.

    PubMed  Google Scholar 

  7. Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Ebert, S., Craig, W. A. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. Journal of Infectious Diseases 1988, 158: 831–847.

    PubMed  Google Scholar 

  8. Gerber, A. U., Wipraechtiger, P., Stettler-Spichiger, U., Lebek, G. Constant infusions of gentamicin compared to intermittent dosing againstPseudomonas aeruginosa in vitro. Journal of Infectious Diseases 1982, 145: 554–560.

    PubMed  Google Scholar 

  9. Blaser, J., Stone, B. B., Groner, M. C., Zinner, S. H. Impact of netilmicin regimens on the activity of ceftazidime-netilmicin combinations againstPseudomonas aeruginosa in an in vitro pharmacokinetic model. Antimicrobial Agents and Chemotherapy 1985, 28: 64–68.

    PubMed  Google Scholar 

  10. Gerber, A. U., Vastola, A. P., Brandel, J., Craig, W. A. Selection of aminoglycoside-resistant subpopulations ofPseudomonas aeruginosa in an in vivo model. Journal of Infectious Diseases 1982, 146: 691–697.

    PubMed  Google Scholar 

  11. Powell, S. H., Thompson, W. L., Luthe, M. A., Stern, R. C., Grossniklaus, D. A., Bloxham, D. D., Groden, D. L., Jacobs, M. R., DiScenna, A. O., Cash, H. A., Klinger, J. D. Once-daily versus continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin. Journal of Infectious Diseases 1983, 147: 918–932.

    PubMed  Google Scholar 

  12. Brugger, H. P., Gerber, A. U., Feller-Segessenmann, C. Bolusinjektion, Kurzinfusion oder Dauerinfusion von Aminoglycosid-Antibiotika? In-vivo-Studie mit Netilmicin undPseudomonas aeruginosa. Schweizerische medizinische Wochenschrift 1983, 113: 1858–1860.

    PubMed  Google Scholar 

  13. Humbert, G., Leroy, A., Fillastrea, J. P., Oksenhendler, G. Pharmacokinetics of netilmicin in the presence of normal or impaired renal function. Antimicrobial Agents and Chemotherapy 1978, 14: 40–44.

    PubMed  Google Scholar 

  14. Mizen, L., Woodnutt, G. A critique of animal pharmacokinetics. Journal of Antimicrobial Chemotherapy 1988, 21: 273–280.

    PubMed  Google Scholar 

  15. Gerber, A. U., Brugger, H. P., Feller, C., Stritzko, T., Stalder, B. Antibiotic therapy of infections due toPseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics. Journal of Infectious Diseases 1986, 153: 90–97.

    PubMed  Google Scholar 

  16. Kapusnik, J. E., Hackbarth, C. J., Chambers, H. F., Carpenter, T., Sande, M. A. Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimentalPseudomonas pneumonia. Journal of Infectious Diseases 1988, 158: 7–12.

    PubMed  Google Scholar 

  17. Pennington, J. E., Stone, R. M. Comparison of antibotic regimens for treatment of experimental pneumonia due toPseudomonas. Journal of Infectious Diseases 1979, 140: 881–889.

    PubMed  Google Scholar 

  18. Jackson, G. G., Riff, L. Pseudomonas bacteremia: pharmacologic and other bases for failure of treatment with gentamicin. Journal of Infectious Diseases 1971, 124, Supplement: 185–191.

    PubMed  Google Scholar 

  19. Moore, R. D., Smith, C. R., Lietman, P. S. The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. Journal of Infectious Diseases 1984, 149: 443–448.

    PubMed  Google Scholar 

  20. Mordenti, J. J., Quintiliani, R., Nightingale, C. H. Combination antibiotic chemotherapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model. Journal of Antimicrobial Chemotherapy 1985, 15, Supplement A: 313–321.

    PubMed  Google Scholar 

  21. Bundtzen, R. W., Gerber, A. U., Cohn, D. L., Craig, W. A. Postantibiotic suppression of bacterial growth. Reviews of Infectious Diseases 1981, 3: 28–37.

    PubMed  Google Scholar 

  22. Vogelman, B., Gudmundsson, S., Turnidge, J., Leggett, J., Craig, W. A. In vivo postantibiotic effect in a thigh infection in neutropenic mice. Journal of Infectious Diseases 1988, 157: 287–298.

    PubMed  Google Scholar 

  23. Moore, R. D., Smith, C. R., Lipski, J. J., Mellits, E. D., Lietman, P. S. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Annals of Internal Medicine 1984, 100: 325–357.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Medicine, Regionalspital, CH-3400, Burgdorf, Switzerland

    A. U. Gerber, S. Kozak, C. Segessenmann, U. Flückiger, T. Bangerter & U. Greter

Authors
  1. A. U. Gerber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Kozak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Segessenmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. Flückiger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Bangerter
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. U. Greter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gerber, A.U., Kozak, S., Segessenmann, C. et al. Once-daily versus thrice-daily administration of netilmicin in combination therapy ofPseudomonas aeruginosa infection in a man-adapted neutropenic animal model. Eur. J. Clin. Microbiol. Infect. Dis. 8, 233–237 (1989). https://doi.org/10.1007/BF01965266

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01965266

Keywords

Search

Navigation